Christopher Smith

Brandon Capital Partners thesis

Advancell Clinical-stage radiopharmaceutical company developing targeted alpha therapies to treat a broad range of cancers. Aravax Pty Ltd Developing peptide-based immunotherapies for food allergy treatment AstronauTx Cutting-edge biotech company founded to target neurodegenerative diseases by improving disrupted physiological processes leading to dementia. Axelia Oncology Biopharmaceutical company aiming to transform the treatment of checkpoint insensitive cancers through the activation of TLR2/6 engagement of the innate immune response. Azura Ophthalmics Developing first-in-class ophthalmic

Sector and stage focus

• Seed: Medical Devices, Pharmaceuticals, BioTech, Therapeutics, Health & Hospital Services
• Pre-seed: Pharmaceuticals, Medical Devices, BioTech, Health & Hospital Services, Therapeutics

Is Christopher Smith a fit for your round?

Upload your pitch deck and see whether Christopher Smith appears in your top 20 matches.